Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Other Accumulated Expenses: 2011-2017

Historic Other Accumulated Expenses for Amicus Therapeutics (FOLD) over the last 6 years, with Dec 2017 value amounting to $5.4 million.

  • Amicus Therapeutics' Other Accumulated Expenses rose 136.03% to $5.4 million in Q4 2017 from the same period last year, while for Dec 2017 it was $5.4 million, marking a year-over-year increase of 136.03%. This contributed to the annual value of $5.4 million for FY2017, which is 136.03% up from last year.
  • As of FY2017, Amicus Therapeutics' Other Accumulated Expenses stood at $5.4 million, which was up 136.03% from $2.3 million recorded in FY2016.
  • Over the past 5 years, Amicus Therapeutics' Other Accumulated Expenses peaked at $5.4 million during FY2017, and registered a low of $275,000 during FY2013.
  • Over the past 2 years, Amicus Therapeutics' median Other Accumulated Expenses value was $3.8 million (recorded in 2016), while the average stood at $3.8 million.
  • Data for Amicus Therapeutics' Other Accumulated Expenses shows a peak YoY skyrocketed of 164.73% (in 2014) over the last 5 years.
  • Amicus Therapeutics' Other Accumulated Expenses (Yearly) stood at $275,000 in 2013, then spiked by 164.73% to $728,000 in 2014, then reached $2.3 million in 2016, then skyrocketed by 136.03% to $5.4 million in 2017.